212 related articles for article (PubMed ID: 27744089)
41. RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study.
Maier LS; Layug B; Karwatowska-Prokopczuk E; Belardinelli L; Lee S; Sander J; Lang C; Wachter R; Edelmann F; Hasenfuss G; Jacobshagen C
JACC Heart Fail; 2013 Apr; 1(2):115-22. PubMed ID: 24621836
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea.
Ibrahim NE; Afilalo M; Chen-Tournoux A; Christenson RH; Gaggin HK; Hollander JE; Kastner P; Levy PD; Mang A; Masson S; Nagurney JT; Nowak RM; Pang PS; Peacock WF; Dipl-Stat VR; Walters EL; Januzzi JL
JACC Heart Fail; 2020 May; 8(5):415-422. PubMed ID: 32354416
[TBL] [Abstract][Full Text] [Related]
43. High-sensitivity C-reactive protein in heart failure with preserved ejection fraction.
DuBrock HM; AbouEzzeddine OF; Redfield MM
PLoS One; 2018; 13(8):e0201836. PubMed ID: 30114262
[TBL] [Abstract][Full Text] [Related]
44. Left ventricular diastolic dysfunction and exercise intolerance in obese heart failure with preserved ejection fraction.
Samuel TJ; Kitzman DW; Haykowsky MJ; Upadhya B; Brubaker P; Nelson MB; Hundley WG; Nelson MD
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1535-H1542. PubMed ID: 33577436
[TBL] [Abstract][Full Text] [Related]
45. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
[TBL] [Abstract][Full Text] [Related]
46. The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.
Obokata M; Kane GC; Reddy YNV; Melenovsky V; Olson TP; Jarolim P; Borlaug BA
Eur Heart J; 2019 Dec; 40(45):3707-3717. PubMed ID: 31513270
[TBL] [Abstract][Full Text] [Related]
47. Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction.
Hasselberg NE; Haugaa KH; Sarvari SI; Gullestad L; Andreassen AK; Smiseth OA; Edvardsen T
Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):217-24. PubMed ID: 25552469
[TBL] [Abstract][Full Text] [Related]
48. Energetic Basis for Exercise-Induced Pulmonary Congestion in Heart Failure With Preserved Ejection Fraction.
Burrage MK; Hundertmark M; Valkovič L; Watson WD; Rayner J; Sabharwal N; Ferreira VM; Neubauer S; Miller JJ; Rider OJ; Lewis AJM
Circulation; 2021 Nov; 144(21):1664-1678. PubMed ID: 34743560
[TBL] [Abstract][Full Text] [Related]
49. Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy.
Abbasi SA; Shah RV; McNulty SE; Hernandez AF; Semigran MJ; Lewis GD; Jerosch-Herold M; Kim RJ; Redfield MM; Kwong RY
PLoS One; 2016; 11(11):e0164914. PubMed ID: 27812147
[TBL] [Abstract][Full Text] [Related]
50. Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.
Santos AB; Kraigher-Krainer E; Bello N; Claggett B; Zile MR; Pieske B; Voors AA; McMurray JJ; Packer M; Bransford T; Lefkowitz M; Shah AM; Solomon SD
Eur Heart J; 2014 Jan; 35(1):42-7. PubMed ID: 24164863
[TBL] [Abstract][Full Text] [Related]
51. Obesity and heart failure with preserved ejection fraction.
Ternushchak TM; Tovt-Korshynska MI; Moskal OM; Kaliy VV; Griadil TI; Feysa SV
Wiad Lek; 2024; 77(3):551-556. PubMed ID: 38691799
[TBL] [Abstract][Full Text] [Related]
52. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.
Bishu K; Deswal A; Chen HH; LeWinter MM; Lewis GD; Semigran MJ; Borlaug BA; McNulty S; Hernandez AF; Braunwald E; Redfield MM
Am Heart J; 2012 Nov; 164(5):763-770.e3. PubMed ID: 23137508
[TBL] [Abstract][Full Text] [Related]
53. Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
Kosmala W; Rojek A; Przewlocka-Kosmala M; Wright L; Mysiak A; Marwick TH
J Am Coll Cardiol; 2016 Oct; 68(17):1823-1834. PubMed ID: 27765184
[TBL] [Abstract][Full Text] [Related]
54. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
Borlaug BA; Lewis GD; McNulty SE; Semigran MJ; LeWinter M; Chen H; Lin G; Deswal A; Margulies KB; Redfield MM
Circ Heart Fail; 2015 May; 8(3):533-41. PubMed ID: 25782985
[TBL] [Abstract][Full Text] [Related]
55. Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study.
Nah EH; Kim SY; Cho S; Kim S; Cho HI
BMJ Open; 2019 Apr; 9(4):e026030. PubMed ID: 31005928
[TBL] [Abstract][Full Text] [Related]
56. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial.
Anker SD; Butler J; Filippatos G; Shahzeb Khan M; Ferreira JP; Bocchi E; Böhm M; Brunner-La Rocca HP; Choi DJ; Chopra V; Chuquiure E; Giannetti N; Gomez-Mesa JE; Janssens S; Januzzi JL; Gonzalez-Juanatey JR; Merkely B; Nicholls SJ; Perrone SV; Piña IL; Ponikowski P; Senni M; Seronde MF; Sim D; Spinar J; Squire I; Taddei S; Tsutsui H; Verma S; Vinereanu D; Zhang J; Jamal W; Schnaidt S; Schnee JM; Brueckmann M; Pocock SJ; Zannad F; Packer M;
Eur J Heart Fail; 2020 Dec; 22(12):2383-2392. PubMed ID: 33251670
[TBL] [Abstract][Full Text] [Related]
57. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
[TBL] [Abstract][Full Text] [Related]
58. Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?
Fudim M; Kelly JP; Jones AD; AbouEzzeddine OF; Ambrosy AP; Greene SJ; Reddy YNV; Anstrom KJ; Alhanti B; Lewis GD; Hernandez AF; Felker GM
Am Heart J; 2020 Feb; 220():97-107. PubMed ID: 31805424
[TBL] [Abstract][Full Text] [Related]
59. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study.
Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
Arch Cardiovasc Dis; 2014 Feb; 107(2):112-21. PubMed ID: 24388161
[TBL] [Abstract][Full Text] [Related]
60. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial.
Kitzman DW; Brubaker PH; Herrington DM; Morgan TM; Stewart KP; Hundley WG; Abdelhamed A; Haykowsky MJ
J Am Coll Cardiol; 2013 Aug; 62(7):584-92. PubMed ID: 23665370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
